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Micro-­‐‑irradiators  enable  exploration  of  the  efficacy  of  novel  radiation  treatment  
approaches  by  providing  the  capability  to  reproduce  realistic  treatment  delivery  in  small  
animal  models.    An  approach  of  current  topical  interest  is  hypofractionated  stereotactic  
body  radiation  therapy  (SBRT),  and  the  study  of  associated  tumor  and  normal  tissue  
radio-­‐‑biology.    Rodent  SBRT  is  extremely  challenging,  requiring  the  precise  delivery  of  
radiation  beams  on  the  order  of  several  millimeters.    At  present  there  are  no  methods  to  
comprehensively  verify  these  delivery  techniques  due  to  the  requirements  for  ultra-­‐‑high  
resolution  and  ability  to  measure  the  dose  in  3  dimensions  (3D).            
This  work  introduces  a  potential  solution  to  the  rodent  SBRT  verification  
challenge:  radiochromic  rodent-­‐‑morphic  3D  dosimeters  compatible  with  ultra-­‐‑high  
resolution  optical  computed  tomography  (optical-­‐‑CT)  dose  read-­‐‑out.    Rodent-­‐‑morphic  
dosimeters  were  produced  by  3D-­‐‑printing  molds  of  rodent  anatomy  directly  from  X-­‐‑ray  
CT  data,  and  using  these  molds  to  create  tissue-­‐‑equivalent  phantoms  both  with  and  
without  high-­‐‑Z  spinal  inserts  for  cone-­‐‑beam  CT  targeting.    Feasibility  was  evaluated  
through  a  series  of  irradiations,  including  a  180-­‐‑degree  spinal  arc  treatment.    Dose  
distributions  were  measured  in  high-­‐‑resolution  (0.5mm  isotropic  voxels)  with  an  in-­‐‑
house  built  optical-­‐‑CT  system,  which  determined  dose  from  the  change  in  optical  
density  throughout  the  dosimeters  from  pre-­‐‑and  post-­‐‑irradiation  scans.    Optical-­‐‑CT  data  
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was  calibrated  to  absolute  dose  using  a  calibration  curve  determined  from  irradiating  
small  volumes  of  radiochromic  material  from  the  same  batch  as  the  rodent-­‐‑morphic  
dosimeters  to  known  doses  in  a  6MV  beam  (negligible  energy  response  was  assumed).    
Independent  verification  of  absolute  dose  at  a  point  was  made  with  a  novel  scintillator  
comprised  of  europium  and  lithium  doped  yttrium  oxide  nanocrystals,  with  a  sub-­‐‑mm  
active  length.  Independent  verification  of  the  dose  distribution  was  performed  using  
EBT2  radiochromic  film  positioned  in  the  dosimeters,  which  had  been  sliced  in  half.    
Contrast-­‐‑to-­‐‑noise  ratio  between  high-­‐‑Z  spinal  inserts  and  tissue-­‐‑equivalent  PRESAGE  
material  was  found  to  be  ~10,  sufficient  for  bony  alignment  and  isocenter  targeting  with  
on-­‐‑board  CBCT  image  guidance.    Absolute  dose  calculated  at  isocenter  through  optical-­‐‑
CT  was  found  to  agree  with  nano-­‐‑detector  measurement  within  3%,  while  relative  dose  
distributions  in  two  orthogonal  planes  were  found  to  agree  with  film  within  4%.    
PRESAGE  rodent-­‐‑morphic  dosimeters  demonstrated  much  promise  in  the  verification  of  
precise  radiation  treatment  given  by  the  X-­‐‑Rad  225Cx  micro-­‐‑irradiator.      
Practical  challenges  involved  in  optical-­‐‑CT  imaging  were  addressed  through  the  
investigation  of  an  in-­‐‑house  Fresnel-­‐‑based  optical-­‐‑CT  system  with  considerably  less  
refractive  index-­‐‑matching  fluid.    The  “DFOS”  (Duke  Fresnel-­‐‑based  Optical-­‐‑CT  System)  
system  differed  from  current  optical-­‐‑CT  systems  by  replacing  cumbersome  convex  
telecentric  lenses  with  a  lighter  and  much  less  expensive  Fresnel  system.    A  second  
major  modification  was  the  replacement  of  the  refractive  index-­‐‑matching  fluid  bath  with  
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a  solid  polyurethane  tank.    PRESAGE  radiochromic  dosimeters  were  irradiated  with  
orthogonal  parallel-­‐‑opposed  treatments  and  a  brain  IMRT  treatment  and  dose  
distributions  were  readout  by  the  DFOS  system  and  compared  to  both  treatment  
planning  software  prediction  and  other  in-­‐‑house  optical-­‐‑CT  systems.    Gamma  index  
passing  rate  at  the  3%/3mm  threshold  for  the  two  parallel-­‐‑opposed  and  brain  IMRT  
treatments  were  89.3%,  92.1%,  and  87.5%,  respectively.    The  DFOS  system  showed  
promise  for  3D  dosimetry,  but  the  performance  is  still  substantially  inferior  at  present  to  






Abstract  .........................................................................................................................................  iv	  
List  of  Tables  ..................................................................................................................................  ix	  
List  of  Figures  .................................................................................................................................  x	  
Acknowledgements  ...................................................................................................................  xiv	  
1.  Introduction  ................................................................................................................................  1	  
1.1  Small  Animal  Irradiation  Research  ................................................................................  1	  
1.2  Convenient,  Cost-­‐‑effective  Optical-­‐‑CT  ..........................................................................  3	  
2.  3D  Dosimetry  with  Optical  Computed  Tomography  ..........................................................  4	  
2.1  PRESAGE  radiochromic  dosimeters  ..............................................................................  4	  
2.2  Optical  Computed  Tomography  ....................................................................................  5	  
3.  Rodent-­‐‑morphic  Dosimetry  .....................................................................................................  9	  
3.1  Motivation  ..........................................................................................................................  9	  
3.2  Production  of  anatomically-­‐‑correct  rodent-­‐‑morphic  dosimeters  ............................  10	  
3.2.1  Step  1:  CT  Data  ...........................................................................................................  11	  
3.2.2  Step  2:  3D  Modeling  and  Post-­‐‑Processing  ..............................................................  11	  
3.2.3  Step  3:  3D  Printing  .....................................................................................................  12	  
3.2.4  Step  4:  PRESAGE  Rodent-­‐‑morphic  Dosimeters  ....................................................  13	  
3.3  Treatment  plans  for  rodent-­‐‑morphic  dosimeters  .......................................................  15	  
3.3.1  Rat  prostate  treatment  ...............................................................................................  15	  
3.3.2  Spinal  arc  treatment  ...................................................................................................  16	  
    
viii  
3.3.2.1  Optical-­‐‑CT  readout  .............................................................................................  19	  
3.3.2.2  Absolute  Dose  measurement  ............................................................................  20	  
3.3.3  Mouse  partial  tumor  irradiation  pilot  study  ..........................................................  27	  
3.3.3.1  Rodent-­‐‑morphic  mouse  dosimeter  ..................................................................  28	  
3.4  Rodent-­‐‑morphic  dosimetry  discussion  ........................................................................  30	  
4.  Feasibility  of  ‘Dry’  Scanning  ..................................................................................................  32	  
4.1  DFOS  .................................................................................................................................  32	  
4.2  Treatment  plans  ...............................................................................................................  37	  
4.2.1  Rectangular  orthogonal  parallel-­‐‑opposed  treatment  I  .........................................  39	  
4.2.2  Rectangular  orthogonal  parallel-­‐‑opposed  treatment  II  ........................................  39	  
4.2.3  Brain  IMRT  treatment  ................................................................................................  40	  
4.3  Results  of  ‘Dry’  Scan  Comparison  ................................................................................  41	  
4.3.1  Line  Profiles  –  Parallel-­‐‑opposed  treatment  I  ..........................................................  50	  
4.3.2  Line  Profiles  –  Parallel-­‐‑opposed  treatment  II  ........................................................  52	  
4.3.3  Line  Profiles  –  Brain  IMRT  treatment  .....................................................................  54	  
4.4  ‘Dry’  Scan  Discussion  .....................................................................................................  55	  
5.  Conclusion  ................................................................................................................................  57	  




List of Tables 
Table  1  –  Specifications  of  in-­‐‑house  optical-­‐‑CT  systems  available  in  the  Duke  3D  
Dosimetry  and  Bio-­‐‑Imaging  Lab  .................................................................................................  6	  
Table  2  –  Summary  of  all  scanner  comparison  parameters,  including:  treatment  
description,  dosimeter  formulation  description,  systems  being  compared,  and  delay  
between  treatment  and  post-­‐‑irradiation  scan.  .........................................................................  38	  





List of Figures 
Figure  1  -­‐‑  Schematic  of  DLOS  optical-­‐‑CT  System  (Image  courtesy  of  Andy  Thomas,  PhD)
  ..........................................................................................................................................................  7	  
Figure  2  –  Example  of  optical-­‐‑CT  projection  images  pre-­‐‑irradiation  (left),  post-­‐‑irradiation  
(center)  and  axial  reconstructed  slice  (right-­‐‑  position  in  dosimeter  shown  with  solid  
green  arrows).  ................................................................................................................................  8	  
Figure  3  –  Illustration  of  workflow  for  producing  rodent-­‐‑morphic  dosimeters  from  CT  
data.    Rodent  CT  data  (a)  is  converted  to  3D  meshes  (b)  for  printing  3D  positive  molds  
(c),  which  are  used  to  make  negative  molds  for  constructing  PRESAGE  dosimeters  (d  –  
optical-­‐‑CT  projection  shown  to  highlight  spinal  insert).  .......................................................  14	  
Figure  4  –  Reconstructed  optical-­‐‑density  change  with  0.5mm  isotropic  voxels.    Five  
incident  coplanar  beams  are  shown  to  converge  at  isocenter  (solid  red  arrows).    Slight  
edge  artifacts  are  noticeable  (dashed  blue  arrows).  ...............................................................  16	  
Figure  5  –  CBCT  of  imaging  (top  row)  and  dosimetric  (middle  row)  phantom  in  three  
orthogonal  views.    Proper  alignment  can  be  seen  in  all  three  views  with  phantom  images  
overlaid  (bottom  row).    The  high-­‐‑Z  spinal  insert  is  visible  in  the  imaging  phantom,  
allowing  isocenter  targeting.  Some  artifacts  remain  –  Top  Right:  The  high  attenuation  (bright  
white)  artifact  is  produced  by  a  small  piece  of  metal  remaining  in  the  dosimeter  from  production.  
Imaging  and  isocenter  placement  is  unaffected.  Bottom  Row:    The  rings  in  the  center  are  
misaligned  due  to  the  images  being  taken  before  isocenter  adjustment.  .......................................  18	  
Figure  6  –  Lead  block  (~3mm  thick)  cutout  (left)  used  to  divide  radiation  field  into  large  
and  small  regions,  along  cone-­‐‑beam  projection  image  of  actual  radiation  field  at  
isocenter  (right).  ...........................................................................................................................  19	  
Figure  7  –  Rodent-­‐‑morphic  PRESAGE  sensitivity  in  [OD/Gy-­‐‑cm]  determined  from  
cuvette  data.  Formulation:  o-­‐‑Meo  LMG  1.5%  .........................................................................  20	  
Figure  8  –  Setup  for  absolute  dose  measurement  at  isocenter  with  a  novel  nano-­‐‑
scintillation  detector.    First,  the  detector  was  calibrated  with  a  RadCal  0.18cc  ion  
chamber  (left),  then  the  180-­‐‑degree  arc  treatment  was  delivered  three  times  with  the  
scintillating  detector  placed  at  the  rodent-­‐‑morphic  dosimeter  isocenter  (center,  right).  ..  22	  
Figure  9  -­‐‑  Bi-­‐‑quadratic  fit  of  radiochromic  film  used  for  absolute  dose  verification.  .......  23	  
    
xi  
Figure  10  -­‐‑  Schematic  showing  placement  of  radiochromic  film  for  independent  
measurement  of  dose  distributions.  ..........................................................................................  24	  
Figure  11  -­‐‑  Axial  dose  distributions  measured  with  optical-­‐‑CT  (top  row)  and  EBT2  film  
(middle  row),  with  comparative  line  profiles  (bottom  row).  ................................................  25	  
Figure  12  -­‐‑  Coronal  dose  distributions  measured  with  optical-­‐‑CT  (top  row)  and  EBT2  
film  (middle  row),  with  comparative  line  profiles  (bottom  row).    Profile  4  shows  a  dose  
underestimate  with  optical-­‐‑CT.    This  may  be  due  to  partial  volume  effects  in  
reproducing  dose  in  the  3mm-­‐‑wide  field  with  0.5mm  voxels.  .............................................  26	  
Figure  13  -­‐‑  PRESAGE  dose  distributions  overlaid  on  original  rat  CT  from  which  the  3D  
printing  was  made,  in  axial  (left)  and  coronal  (right)  planes.  ...............................................  27	  
Figure  14  -­‐‑  3D  mesh  file  (top  left)  created  from  mouse  CT  data  and  used  for  PRESAGE  
mouse  dosimeters  (top  right,  American  penny  for  scale).    The  bottom  image  shows  an  
optical-­‐‑CT  projection  taken  with  the  DmicrOS  system.  .........................................................  29	  
Figure  15  -­‐‑  Preliminary  partial  tumor-­‐‑irradiation  data  showing  sharp  dose  drop-­‐‑off  at  
full  field/  blocked  field  interface.  ..............................................................................................  30	  
Figure  16  -­‐‑  Comparison  of  parallel-­‐‑beam  collimation  from  Fresnel  and  Convex  lenses.    
Equivalent  power  Fresnel  lenses  may  be  100X  less  expensive  and  close  to  15X  lighter  
than  convex  collimating  lenses.  .................................................................................................  33	  
Figure  17  -­‐‑  Non-­‐‑uniformities  caused  by  Fresnel  grooves  (left)  may  be  reduced  by  
increasing  the  f-­‐‑stop  (right)  at  the  imaging  lens.    Remaining  non-­‐‑uniformities  are  
corrected  by  acquiring  pre-­‐‑  and  post-­‐‑irradiation  images.  .....................................................  34	  
Figure  18  -­‐‑  Flood  field  acquired  by  filling  the  DFOS  polyurethane  tank  with  RI-­‐‑matching  
fluid  (left).    Matching  the  fluid  to  the  tank  achieves  good  uniformity  all  the  way  to  the  
edges,  but  immersing  a  dosimeter  of  different  refractive  index  into  the  fluid  causes  
mismatching  artifacts  at  the  edge  (right).    This  phenomena,  combined  with  the  desire  to  
minimize  fluid  handling,  drove  the  decision  to  omit  the  flood  field  altogether.  ...............  35	  
Figure  19  -­‐‑  Comparison  of  line  profile  through  a  slice  reconstructed  with  and  without  a  
flood  field  projection.    Maximum  computed  dose  error  in  this  case  is  only  4.2  cGy.  .......  37	  
Figure  20  -­‐‑  Rectangular  parallel-­‐‑opposed  I  (left),  II  (center)  and  five-­‐‑field  brain  IMRT  
(right)  treatment  plans  from  Eclipse  TPS.  ................................................................................  41	  
    
xii  
Figure  21  -­‐‑  Eclipse  predicted  dose  (left),  DFOS  reconstructed  dose  (middle)  and  3%/3mm  
gamma  maps  (right)  for  three  orthogonal  planes  in  parallel-­‐‑opposed  treatment  plan  I.  .  44	  
Figure  22  -­‐‑  Eclipse  predicted  dose  (left),  DFOS  reconstructed  dose  (second  column),  
DMOS  reconstructed  dose  (third  column)  and  DLOS  reconstructed  dose  (right)  for  three  
orthogonal  planes  in  parallel-­‐‑opposed  treatment  plan  II.  .....................................................  45	  
Figure  23  -­‐‑  Three  orthogonal  views  of  3%/3mm  gamma  maps  for  DFOS  (column  2),  
DMOS  (column  3),  and  DLOS  (right)  systems,  with  passing  rates.    Eclipse  dose  views  
(left)  for  reference.  .......................................................................................................................  46	  
Figure  24  -­‐‑  Eclipse  predicted  dose  (left),  DFOS  reconstructed  dose  (middle)  and  DLOS  
dose  (right)  for  three  orthogonal  views  in  brain  IMRT  plan.  ................................................  47	  
Figure  25  -­‐‑  Three  orthogonal  views  of  3%/3mm  gamma  maps  for  DFOS  (column  2)  and  
DLOS  (right)  systems,  with  passing  rates.    Eclipse  dose  views  (left)  for  reference.  ..........  48	  
Figure  26  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  I  comparing  Eclipse  prediction  
(black),  and  DFOS  dose  (blue).  ..................................................................................................  50	  
Figure  27  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  I  comparing  Eclipse  prediction  
(black),  and  DFOS  dose  (blue).  ..................................................................................................  50	  
Figure  28  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  I  comparing  Eclipse  prediction  
(black),  and  DFOS  dose  (blue).  ..................................................................................................  51	  
Figure  29  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  II  comparing  Eclipse  prediction  
(black),  DFOS  (blue),  DMOS  (green),  and  DLOS  (red)  dose.  ................................................  52	  
Figure  30  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  II  comparing  Eclipse  prediction  
(black),  DFOS  (blue),  DMOS  (green),  and  DLOS  (red)  dose.  ................................................  52	  
Figure  31  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  II  comparing  Eclipse  prediction  
(black),  DFOS  (blue),  DMOS  (green),  and  DLOS  (red)  dose.  ................................................  53	  
Figure  32  -­‐‑  Line  profiles  for  brain  IMRT  treatment  comparing  Eclipse  prediction  (black),  
DFOS  (blue),  and  DLOS  (red)  dose.  ..........................................................................................  54	  
Figure  33  -­‐‑  Line  profiles  for  brain  IMRT  treatment  comparing  Eclipse  prediction  (black),  
DFOS  (blue),  and  DLOS  (red)  dose.  ..........................................................................................  54	  
    
xiii  
Figure  34  -­‐‑  Line  profiles  for  brain  IMRT  treatment  comparing  Eclipse  prediction  (black),  






I  would  like  to  thank  the  following  people  their  time,  assistance,  and  support:  
Thesis  Committee  
Mark  Oldham,  PhD  –  Advisor  (thanks!)  
Shiva  Das,  PhD  
Martin  Tornai,  PhD  
Duke  3D  Dosimetry  and  Bio-­‐‑Imaging  Lab          Small  Animal  Irradiator  
Titania  Juang                                  David  Kirsch,  PhD  
Jake  Jackson                       Hooney  Minn  
Qiongge  Li                       Matt  Belley  
Kelsey  Chisolm                  Hannah  Norris  
Javian  Malcolm                   Rider  University  
Leith  Rankine                     John  Adamovics,  PhD  
Don  Pearce  –  Duke  machine  shop            Ron  Benning  
                                                      
Lastly,  and  most  importantly-­‐‑  thank  you  Gretchen  Leigh  Guggenheim  for  staying  by  my  
side,  and  for  agreeing  to  marry  me  after  Graduate  School!  
  
This  work  was  partially  supported  by  NIH  R01CA100835.
     1  
1. Introduction  
  
1.1 Small Animal Irradiation Research  
The  current  assumption  in  radiation  treatment  for  cancer  is  that  the  most  
effective  way  to  treat  a  region  of  cancerous  cells  is  to  irradiate  the  entire  volume  with  as  
high  a  dose  as  possible  while  sparing  normal  tissue.    In  recent  years,  however,  the  ability  
to  investigate  complex  radiation  deliveries  and  associated  radio-­‐‑response  has  been  made  
possible  through  small  animal  radiation  research  platforms1-­‐‑6.    This  pre-­‐‑clinical  setting  is  
important  for  exploring  tumor  radio-­‐‑response  in  small  animal  tumor  models.    Small  
animal  micro-­‐‑irradiators  such  as  the  X-­‐‑Rad  225Cx  (Precision  X-­‐‑Ray,  N.  Banfield,  CT)  
allow  precise,  image-­‐‑guided  treatment  to  small  animals  (e.g.  rats  or  mice)  with  field  
sizes  as  small  as  10x10  mm2.    Investigations  of  tumor  response  in  differing  radiation  
treatment  courses  such  as  extreme  hypo-­‐‑fractionation  and  partial-­‐‑tumor  irradiation  have  
become  possible  in  this  pre-­‐‑clinical  small  animal  setting.    This  is  similar  to  early  phase  
clinical  trials  of  new  drugs,  where  rodent  studies  are  completed  before  translating  to  
human  populations.      
It  is  important  to  note  that  this  pre-­‐‑clinical  radiotherapy  setting  should  not  only  
be  scaled  down  in  geometry,  but  also  in  energy.    The  use  of  MV  beams  in  small  animal  
radiotherapy  is  ill  advised  due  to  dose  buildup  regions  at  the  specimen  surface,  as  well  
as  field  penumbra  with  sizes  on  the  order  of  the  entire  specimen  itself.    The  use  of  kV  
     2  
beams  (225  kVp  for  the  X-­‐‑Rad225Cx)  introduces  the  challenge  of  high-­‐‑resolution  
treatment  planning  and  verification,  where  commercial  treatment  planning  software  is  
inaccurate.    
Investigation  into  high-­‐‑resolution  treatment  planning  and  dose  verification  is  
necessary.    Software  utilizing  Monte-­‐‑Carlo  simulation  and  superposition  convolution  
methods  are  of  current  interest  for  small  animal  treatment  planning7-­‐‑10.  In  this  work,  the  
challenge  of  measuring  high-­‐‑resolution  3D  dose  distributions  given  by  a  small  animal  
micro-­‐‑irradiator  is  addressed.    High-­‐‑resolution,  rodent-­‐‑morphic  PRESAGE  dosimeters  
were  produced,  with  3D  dose  readout  accomplished  through  the  use  of  optical-­‐‑CT.    This  
section  is  organized  as  follows:  Chapter  2  contains  a  brief  description  of  the  custom  
optical-­‐‑CT  readout  system  available  in  the  Duke  University  3D  dosimetry  and  bio-­‐‑
imaging  lab,  as  well  as  the  radio-­‐‑response  characteristics  of  PRESAGE  radiochromic  
dosimeters  (Hueris  Pharma,  Skillman,  NJ).    Chapter  3  introduces  a  series  of  novel  
rodent-­‐‑morphic  PRESAGE  dosimeters  produced  through  3D  printing  of  rodent  molds  
directly  from  CT  data.    The  rodent-­‐‑morphic  dosimeters  were  developed  for  use  in  
imaging  high-­‐‑resolution  3D  dose  distributions  given  by  the  X-­‐‑Rad  225Cx  small  animal  
irradiator  at  Duke.    Quantitative  analysis  of  a  rodent  stereotactic  body  radiation  therapy  
(SBRT)  treatment  delivered  to  a  rodent-­‐‑morphic  phantom  is  discussed.    
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1.2 Convenient, Cost-effective Optical-CT 
Chapter  4  describes  an  investigation  into  the  feasibility  of  a  more  convenient  and  
cost-­‐‑effective  “dry”  optical-­‐‑CT  scanner.    This  “DFOS”  (Duke  Fresnel-­‐‑based  Optical-­‐‑CT  
System)  attempts  to  address  two  difficulties  associated  with  optical-­‐‑CT  scanning.    It  
utilizes:  (1)  a  telecentric  Fresnel  lens  system,  reducing  weight  and  cost  compared  to  
standard  convex  telecentric  lenses  and  (2)  a  polyurethane  tank  for  minimizing  the  
amount  of  refractive-­‐‑index  matching  fluid  needed  to  read  out  high-­‐‑resolution  3D  dose  
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2. 3D Dosimetry with Optical Computed Tomography 
Several  materials  and  methods  for  imaging  3D  dose  distributions  have  been  
proposed  and  utilized.    Gels  doped  with  an  aqueous  ferrous  sulfate  solution  (Fricke  
gels)  allow  both  MR  and  optical  readout  of  dose  distributions11,  12.    Fricke  gel  dosimetry  
works  through  the  dose  dependent  transformation  of  ferrous  ions  (Fe2+)  to  ferric  ions  
(Fe3+),  which  causes  a  paramagnetic  shift  observable  with  MRI13.    Resolution  is  limited  in  
Fricke  gels  due  to  the  diffusion  of  ferric  ions  post-­‐‑irradiation  blurring  the  dose  
distribution.    Similarly,  polymer  gels  display  a  change  in  opacity  upon  irradiation  due  to  
a  dose  dependent  polymerization  within  the  gel14,  15.    Imaging  of  opacity  change  in  
polymer  gels,  and  therefore  dose,  through  optical-­‐‑CT  relies  on  the  differential  scattering  
of  incident  visible  light.    The  scattering  from  polymers  is  not  ideally  localized,  which  can  
also  blur  the  3D  dose  distribution16.    For  highly  localized  and  thus  high-­‐‑resolution  3D  
dosimetry,  dose-­‐‑dependent  differential  light  absorbance  is  an  attractive  alternative  to  
both  paramagnetic  changes  and  optical  scattering.  
  
2.1 PRESAGE radiochromic dosimeters 
PRESAGE  dosimeters  consist  of  an  optically  clear  polyurethane  matrix  doped  
with  a  radiochromic  leuco-­‐‑dye17.    The  leuco-­‐‑dye,  leucomalachite  green  (LMG),  changes  
light  absorbance  when  exposed  to  ionizing  radiation,  which  can  be  quantified  as  a  
change  in  optical  density.    The  advantage  of  differential  absorbance  upon  irradiation  is  
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the  truly  local  nature  of  the  dose-­‐‑dependent  change  in  the  dosimeter.    PRESAGE  
characteristics  have  been  well  documented  to  show  a  linear  change  in  optical  density  
with  respect  to  absorbed  dose  that  is  dose-­‐‑rate  and  energy  independent18,  19.    PRESAGE  
is  also  insensitive  to  oxygen  and  visible  light,  and  can  be  cast  and  cured  in  a  variety  of  
shapes.    PRESAGE  material  is  generally  made  to  be  tissue  equivalent,  but  the  effective  
atomic  number  may  be  changed  by  altering  the  relative  proportions  of  leuco-­‐‑dye  and  
initiator20  used  in  production.    A  further  benefit  of  PRESAGE  optical  dose  readout  is  the  
ability  to  deliver  dose  treatments  to  moving  or  deformed21  phantoms,  mimicking  
difficult  planning  and  verification  scenarios  seen  in  the  clinic.    Readout  of  dose  
distributions  in  PRESAGE  dosimeters  is  accomplished  through  optical-­‐‑CT,  described  in  
the  next  section.  Examples  of  past  usage  of  PRESAGE  3D  dosimetry  include  head  and  
neck  treatment  verification22,  as  well  as  the  commissioning23  and  image-­‐‑guidance  
verification24  for  the  X-­‐‑Rad  225Cx  small  animal  irradiator  at  Duke  University.            
  
2.2 Optical Computed Tomography  
   Optical  computed  tomography,  or  optical-­‐‑CT,  was  first  introduced  in  1996  for  
imaging  dose  distributions  in  polymer  gels25,  and  is  the  visible  light  analogue  to  first-­‐‑
generation  X-­‐‑ray  CT.    For  this  work,  in-­‐‑house  optical-­‐‑CT  systems  of  differing  scales  were  
used  for  all  imaging.    Some  features  of  each  system  referenced  in  this  paper  are  listed  in  
Table  1.  
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Table  1  –  Specifications  of  in-­‐‑house  optical-­‐‑CT  systems  available  in  the  Duke  3D  
Dosimetry  and  Bio-­‐‑Imaging  Lab  
  
  
Figure  1  shows  a  schematic  of  the  Duke  Large  FOV  Optical–CT  System  (DLOS)  
first  described  in  Thomas  et  al26  in  2010  and  benchmarked  in  201127.    To  obtain  
volumetric  dose  data  within  the  dosimeter,  a  sample  is  immersed  in  a  refractive  index-­‐‑
matching  bath  and  placed  on  a  stage  within  the  FOV  of  a  matched  telecentric  source  and  
imaging  lens  (Edmund  Optics,  Barrington,  NJ).    The  fluid  minimizes  deviation  from  
parallel  beam  incidence  at  the  sample  interfaces  by  eliminating  refractive  index  
mismatching  (further  discussion  in  Chapter  4).  An  LED  with  peak  output  at  632nm  and  
+/-­‐‑  10nm  filter  (to  match  peak  PRESAGE  response)  is  collimated  into  parallel-­‐‑beam  
geometry  and  used  to  illuminate  the  sample.    Typically  360  projections  of  differentially  
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attenuating  line  paths  are  made  at  1-­‐‑degree  increments  and  captured  after  collimation  
by  a  CCD  array  (Basler,  Germany).    
  
Figure  1  -­‐‑  Schematic  of  DLOS  optical-­‐‑CT  System  (Image  courtesy  of  Andy  Thomas,  
PhD)  
  
The  quantity  of  interest  in  optical-­‐‑CT  with  PRESAGE  is  the  change  in  optical  








' ,  where  
I0  is  the  incident  optical  intensity  and  I  is  the  intensity  through  the  sample.    To  
reconstruct  optical  density  change  throughout  the  volume,  intensity  projections  through  
the  sample  must  be  made  both  pre-­‐‑  and  post-­‐‑irradiation,  as  well  as  initial  intensity  
projections.    Initial  intensity  I0  is  measured  both  pre-­‐‑  and  post-­‐‑irradiation  through  a  
“flood”  field  –  a  projection  through  the  refractive  index-­‐‑matching  fluid  filled  tank  
without  the  dosimeter  emerged.    The  flood  field  is  discussed  further  in  Chapter  4  
3D  reconstructions  of  optical  density  change  in  PRESAGE  dosimeters  are  made  
through  filtered  back-­‐‑projection  with  a  custom  MATLAB  (MathWorks,  Natick,  MA)  GUI  
     8  
in  high-­‐‑resolution  (up  to  0.5mm  isotropic)  voxels.      Figure  2  shows  a  representative  pre-­‐‑  




Figure  2  –  Example  of  optical-­‐‑CT  projection  images  pre-­‐‑irradiation  (left),  post-­‐‑
irradiation  (center)  and  axial  reconstructed  slice  (right-­‐‑  position  in  dosimeter  shown  
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3. Rodent-morphic Dosimetry 
 
3.1 Motivation 
For  the  geometry  and  scales  of  clinical  radiation  treatment,  a  cylindrical  
dosimeter  is  adequate  for  comparing  dose  distributions  calculated  with  PRESAGE  and  
optical-­‐‑CT  with  predicted  distributions  given  by  treatment  planning  software  such  as  
Eclipse  [Varian  Medical  Systems,  Palo  Alto,  CA].    For  dosimetric  considerations  in  the  
small  animal  setting,  however,  a  more  precise  dosimeter  design  is  desired.  
In  recent  years,  much  effort  has  been  given  to  the  development  of  precise,  image-­‐‑
guided  small  animal  irradiators  for  complex  radiotherapy  treatment  in  small  animal  
tumor  models.    Investigation  of  the  efficacy  and  biological  radio-­‐‑response  from  new  
radiation  treatments  rely  on  the  use  of  these  small  animal  models  before  reaching  the  
clinic.  Pre-­‐‑clinical  studies  aim  to  highlight  the  biological  mechanisms  governing  
radiotherapy  response  in  many  radiation  applications2-­‐‑4,  28.  
With  more  complex  radiotherapy  techniques  being  investigated  comes  a  need  for  
a  high-­‐‑resolution  3D  measurement  of  dose  distributions  given  by  small  animal  micro-­‐‑
irradiators  such  as  the  X-­‐‑Rad225Cx.    Current  practice  in  small  animal  dosimetry  rely  on  
film  or  TLD  measurements  of  radiation  output  of  small  field  therapy  machines  at  
acceptance  and  commissioning  in  the  form  of  tabulated  percent-­‐‑depth-­‐‑dose  (PDD)  
curves,  with  beam-­‐‑on-­‐‑time  for  a  specified  delivered  dose  calculated  from  these  lookup  
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tables.    A  high-­‐‑resolution,  3D  dose  readout  is  desired  for  radiotherapy  treatments  given  
my  small  animal  irradiators,  as  well  as  for  verification  of  treatment  planning  software,  
which  is  becoming  more  widely  available.      
For  this  investigation,  high-­‐‑resolution  rodent-­‐‑morphic  PRESAGE  dosimeters  
were  produced  utilizing  3D  printing  of  rodent  anatomy  directly  from  CT  data.    These  
anatomically  accurate  dosimeters  were  produced  in  order  to  mimic  exact  rodent  
contours  and  internal  structures,  for  dose  readout  with  high-­‐‑resolution  optical-­‐‑CT.        
  
3.2 Production of anatomically-correct rodent-morphic 
dosimeters 
Evaluation  of  the  rodent-­‐‑morphic  dosimeters  involved  (a)  establishing  the  
feasibility  of  manufacture  both  with  and  without  high-­‐‑Z  heterogeneous  inserts  (such  as  
bone),  (b)  verification  of  sufficient  bony/soft-­‐‑tissue  contrast  for  representative  CBCT  
image-­‐‑guided  positioning,  and  (c)  achievability  of  relative  dose-­‐‑readout  by  optical-­‐‑CT  in  
high  resolution  (0.5mm  isotropic  voxels),  with  absolute  dose  verification  at  isocenter.    
The  general  workflow  for  producing  rodent-­‐‑morphic  dosimeters  involved  (1)  obtaining  
a  CT  of  the  rodent  of  interest,  (2)  conversion  of  rodent  CT  data  to  3D-­‐‑printable  file  
format29,  (3)  3D-­‐‑printing  positive  molds  of  anatomically  correct  outer  contours  and  
spinal  inserts,  and  (4)  using  the  positive  molds  to  produce  tissue  equivalent  PRESAGE  
dosimeters  with  high-­‐‑Z  PRESAGE  bony  inserts.    The  specifics  of  this  workflow  are  
detailed  below  and  show  in  Figure  3.  
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3.2.1 Step 1: CT Data 
For  this  study,  a  research  rat  was  scanned  following  IACUC  protocols  with  a  
LightSpeed  RT  (GE  Healthcare,  UK)  CT  system  at  Duke  University  Medical  Center  
Clinic  at  80  kVp  and  75  mAs.    Volumetric  CT  data  was  exported  as  .625  mm  axial  slices  
in  DICOM  (.dcm)  format,  and  imported  into  3D  Slicer  (www.Slicer.org),  an  open-­‐‑source  
software  package  for  visualization  and  image  analysis30.      
  
3.2.2 Step 2: 3D Modeling and Post-Processing  
The  3D  Slicer  software  gives  the  ability  to  contour  structures  and  convert  and  
export  in  stereolithography  (.stl)  file  format.    For  this  study,  a  central  40.1  mm  axial  
portion  of  the  rat  was  selected,  corresponding  to  the  prostate  region  plus  25  mm  and  5  
mm  margins  in  the  superior  and  inferior  directions  respectively.    Both  external  body  and  
spinal  contours  were  drawn  in  3D  Slicer  and  saved  as  individual  structures,  first  with  
automated  Hounsfield  units  segmentation,  then  refined  manually.    Finer  details  outside  
of  the  vertebral  bodies  were  omitted.    A  base  with  thickness  1.875  mm  (3  slices)  
corresponding  to  the  outer  contours  of  the  rat  was  added  to  the  spinal  insert.    This  
allowed  precise  placement  of  the  spine  within  the  rat  body  by  aligning  the  spinal  insert  
base  with  the  outer  body  base.  
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After  segmentation,  3D-­‐‑mesh  files  for  rat  spinal  and  outer  body  contours  were  
imported  into  the  Meshlab  (stylized  meshlab,  sourceforge.meshlab.net)  software  
package,  an  open-­‐‑source  package  for  editing  and  processing  3D  triangular  meshes.    
Additional  post  processing  was  performed  in  meshlab  in  order  to  repair  and  smooth  the  
3D  files,  including  3  Laplacian  smoothing  iterations,  and  deletion  of  any  isolated  
volumes  smaller  than  5%  of  the  maximum  mesh  volume.    Smoothing  was  done  to  
simplify  the  3D  printing  as  well  as  dosimeter  manufacturing  steps,  while  isolated  
volume  deletion  ensures  the  absence  of  any  structures  too  small  to  be  produced  in  the  
slice-­‐‑by-­‐‑slice  manner  used  by  the  3D  printer.      
  
3.2.3 Step 3: 3D Printing  
Smoothed  and  processed  spine  and  body  .stl  files  were  sent  to  be  3D  printed  by  
FineLine  Prototyping  (Raleigh,  NC),  via  additive  manufacturing,  the  process  of  building  
a  model  slice-­‐‑by-­‐‑slice  from  the  bottom  up  using  thin  layers  of  rapidly  cooling  liquid  
plastics.    Anatomical  molds  were  printed  in  0.1  mm  slices  from  liquid  DSM  Somos  
ProtoGen  18420,  a  plastic-­‐‑like  photopolymer31,  with  0.23  mm  resolution  in  each  in-­‐‑slice  
dimension.    These  molds  served  as  the  positive  molds  used  in  the  production  of  the  
PRESAGE  rodent-­‐‑morphic  dosimeters.    
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3.2.4 Step 4: PRESAGE Rodent-morphic Dosimeters  
3D  rodent-­‐‑morphic  dosimeters  were  produced  from  3D-­‐‑printed  molds  in  a  3-­‐‑step  
process:    First,  a  flexible,  removable  mold  was  constructed  from  the  3D  printed  spinal  
mold.    High-­‐‑Z  PRESAGE  material  was  poured  and  cured  to  produce  a  radio-­‐‑chromic  
spinal  insert  with  near-­‐‑bone  equivalent  attenuation.    A  spinal  base  ensured  proper  
alignment  of  the  spine  with  respect  to  the  outer  body  contours.    Next,  a  similar  mold  
was  produced  using  the  3D  printed  body.    The  spinal  insert  was  placed  into  the  body  
mold,  and  lower-­‐‑Z  (tissue  equivalent)  PRESAGE  material  was  poured  into  the  mold  and  
cured.    This  resulted  in  a  PRESAGE  radiochromic  dosimeter,  with  outer  contours  and  
high-­‐‑Z  spinal  insert  derived  directly  from  rat  CT  data.  
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Figure  3  –  Illustration  of  workflow  for  producing  rodent-­‐‑morphic  dosimeters  from  CT  
data.    Rodent  CT  data  (a)  is  converted  to  3D  meshes  (b)  for  printing  3D  positive  molds  
(c),  which  are  used  to  make  negative  molds  for  constructing  PRESAGE  dosimeters  (d  
–  optical-­‐‑CT  projection  shown  to  highlight  spinal  insert).  
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3.3 Treatment plans for rodent-morphic dosimeters  
Several  treatments  were  designed  and  delivered  for  the  investigation  of  
PRESAGE  rodent-­‐‑morphic  dosimeters.    An  initial  rat  prostate  treatment  served  as  a  pilot  
study  to  investigate  the  feasibility  of  manufacturing  the  dosimeters.  (Section  3.3.1)    In-­‐‑
depth  quantitative  analysis  was  performed  with  a  spinal-­‐‑arc  micro-­‐‑  SBRT  treatment  
(Section  3.3.2),  and  an  ongoing  “marginal-­‐‑miss”  treatment  paradigm  is  being  
investigated  in  a  mouse  version  of  the  rodent-­‐‑morphic  dosimeter  (Section  3.3.3).    
  
3.3.1 Rat prostate treatment 
To  investigate  CBCT  image-­‐‑guidance  and  optical-­‐‑CT  readout,  a  simple  5-­‐‑field  
coplanar  treatment  was  designed.    A  rodent  dosimeter  with  high-­‐‑Z  spinal  insert  was  
placed  on  the  X-­‐‑Rad  225Cx  treatment  stage  and  a  CBCT  was  performed.    Sufficient  
contrast  was  realized  between  the  tissue  equivalent  PRESAGE  and  the  spinal  insert,  and  
isocenter  was  placed  1cm  to  the  spine.    The  phantom  was  irradiated  with  5-­‐‑  2.5mm  
diameter  circular  fields.    Optical  density  change  was  read  out  using  an  in-­‐‑house  Optical-­‐‑
CT  system  analogous  to  the  DLOS  to  feature  a  smaller  FOV  of  17cm  x  17cm.    The  Duke  
Mid-­‐‑Sized  Optical-­‐‑CT  System  (DMOS)  was  used  to  take  360  pre-­‐‑  and  post-­‐‑  irradiation  
projection  images  at  1-­‐‑degree  increments,  and  optical  density  change  was  reconstructed  
with  0.5mm  isotropic  voxels.    Qualitative  evaluation  of  reconstruction  edge  artifacts  and  
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isocentric  beam  convergence  showed  viability  of  the  dosimeters.    Figure  4  shows  proper  
isocentric  beam  alignment  and  minimal  edge  artifacts.  
  
  
Figure  4  –  Reconstructed  optical-­‐‑density  change  with  0.5mm  isotropic  voxels.    Five  
incident  coplanar  beams  are  shown  to  converge  at  isocenter  (solid  red  arrows).    Slight  
edge  artifacts  are  noticeable  (dashed  blue  arrows).  
  
3.3.2 Spinal arc treatment 
For  a  more  quantitative  investigation,  a  treatment  plan  was  devised  in  order  to  
simulate  micro-­‐‑SBRT  (stereotactic  body  radiation  therapy)  spinal  cord  treatments  given  
by  a  180-­‐‑degree  arc.    Accurate  delivery  to  the  rodent  spine  was  accomplished  using  two  
rodent-­‐‑morphic  dosimeters-­‐‑  an  “imaging”  phantom  that  included  the  high-­‐‑Z  spinal  
insert  for  target  alignment  and  isocenter  placement,  and  a  homogeneous  “dosimetric”  
phantom  for  dose  distribution  readout.    The  imaging  phantom  was  first  placed  on  the  
carbon  fiber  treatment  stage  in  a  cardboard  setup-­‐‑jig.    To  achieve  accurate  spinal  
targeting,  CBCT  was  performed  on  the  imaging  phantom  and  isocenter  was  placed  
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directly  on  the  spine.    The  imaging  phantom  was  then  replaced  on  the  treatment  stage  
by  the  dosimetric  phantom,  preserving  isocenter  placement.    Outer  contours  images  
were  overlaid  and  compared  in  order  to  confirm  exact  replacement  of  the  imaging  
phantom  with  the  homogeneous  dosimetric  phantom  [Figure  5].    A  2  cm  (AP)  x  1  cm  
rectangular  cone  was  selected  for  treatment.    A  3mm  lead-­‐‑block  (~4  HVLs)  was  
constructed  and  affixed  to  the  treatment  cone  to  divide  the  2  cm  longitudinal  field  into  a  
1cm  section  and  a  3mm  section  at  isocenter  [Figure  6].    The  dosimeter  was  then  treated  
in  the  supine  position  with  a  180-­‐‑degree  arc  at  225  kVp  and  13  mAs,  through  the  carbon  
fiber  treatment  stage.    
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Figure  5  –  CBCT  of  imaging  (top  row)  and  dosimetric  (middle  row)  phantom  in  three  
orthogonal  views.    Proper  alignment  can  be  seen  in  all  three  views  with  phantom  
images  overlaid  (bottom  row).    The  high-­‐‑Z  spinal  insert  is  visible  in  the  imaging  
phantom,  allowing  isocenter  targeting.  Some  artifacts  remain  –  Top  Right:  The  high  
attenuation  (bright  white)  artifact  is  produced  by  a  small  piece  of  metal  remaining  in  
the  dosimeter  from  production.  Imaging  and  isocenter  placement  is  unaffected.  Bottom  
Row:    The  rings  in  the  center  are  misaligned  due  to  the  images  being  taken  before  
isocenter  adjustment.    
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Figure  6  –  Lead  block  (~3mm  thick)  cutout  (left)  used  to  divide  radiation  field  into  
large  and  small  regions,  along  cone-­‐‑beam  projection  image  of  actual  radiation  field  at  
isocenter  (right).  
  
3.3.2.1  Optical-­‐‑CT  readout  
Optical  density  change  was  computed  from  360  projection  images  at  1-­‐‑degree  
increments  by  the  DMOS  system,  and  reconstructed  with  0.5mm  isotropic  voxels.    In  
order  to  calibrate  PRESAGE  sensitivity,  8-­‐‑  1cm  x  1cm  plastic  “cuvettes”  consisting  of  
PRESAGE  material  from  the  same  batch  used  for  the  rodent-­‐‑morphic  dosimeters  were  
analyzed.    Initial  optical  density  at  633  nm  was  measured  for  each  cuvette  with  a  
Genesys  20  spectrophotometer  (Thermo  Spectronic,  Waltham,  MA),  followed  by  an  
irradiation  of  the  cuvettes  by  a  clinical  LINAC  to  1Gy,  1Gy,  3Gy,  3Gy,  6Gy,  and  6Gy  
(with  two  controls).    Sensitivity  of  the  rodent-­‐‑morphic  dosimeters  in  ΔOD/Gy-­‐‑cm  was  
found  from  a  linear  fit  of  cuvette  data  [Figure  7].      
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Figure  7  –  Rodent-­‐‑morphic  PRESAGE  sensitivity  in  [ OD/Gy-­‐‑cm]  determined  from  
cuvette  data.  Formulation:  o-­‐‑Meo  LMG  1.5%  
  
3.3.2.2  Absolute  Dose  measurement  
Reconstructed  voxel  values  in  OD  change  were  converted  to  dose  through  the  
strong  linear  relationship  between  PRESAGE  OD  change  and  absorbed  dose  (R2  =  
0.99932).    A  cube  ROI  with  3  voxel  (1.5mm)  length  sides  was  centered  about  the  arc  
isocenter  to  account  for  any  setup  error,  and  mean  isocenter  dose  was  found  to  be  9.23  
Gy  with  a  0.093  Gy  standard  deviation.    To  verify  the  accuracy  of  the  PRESAGE  dose  
distribution,  two  measurements  were  made.    First,  a  1mm  channel  was  drilled  into  the  
original  treated  PRESAGE  dosimeter.    NanoFOD  (nano-­‐‑  fiber-­‐‑optic  detector),  a  novel  
europium  and  lithium  doped  yttrium  oxide  nanocrystal-­‐‑based  scintillation  detector32  
was  used  to  confirm  absolute  dose  at  isocenter  [Figure  8].    The  400-­‐‑micron  active  region  
of  the  detector  was  calibrated  in  units  of  integrated  voltage  (V-­‐‑s)  vs.  exposure  (mR)  


















OD	  Change	  vs.	  Dose	  
Δ
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using  a  0.18cc  RadCal  ion  chamber  through  a  series  of  9  30-­‐‑second  open-­‐‑field  
irradiations  with  the  X-­‐‑rad  225Cx  irradiator  –  3  each  at  8,  10,  and  13  mAs.      NanoFOD  
calibration  factor  was  converted  from  V-­‐‑s/mR  to  soft-­‐‑tissue  dose  in  V-­‐‑s/cGy  using  the  
ICRU-­‐‑44  formulation,  and  found  to  be  0.235  V-­‐‑s/cGy.  The  detector  was  then  placed  
inside  the  PRESAGE  channel  after  setup  on  the  X-­‐‑Rad225Cx  treatment  stage  [Figure  8].    
The  original  180-­‐‑degree  arc  treatment  was  repeated  3  times  with  the  active  region  of  the  
detector  at  treatment  isocenter.    The  average  converted  tissue  (and  PRESAGE)  dose  to  
isocenter  was  found  to  be  of  9.49  Gy    (standard  deviation  =  0.0085  Gy),  an  absolute  dose  
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Figure  8  –  Setup  for  absolute  dose  measurement  at  isocenter  with  a  novel  nano-­‐‑
scintillation  detector.    First,  the  detector  was  calibrated  with  a  RadCal  0.18cc  ion  
chamber  (left),  then  the  180-­‐‑degree  arc  treatment  was  delivered  three  times  with  the  
scintillating  detector  placed  at  the  rodent-­‐‑morphic  dosimeter  isocenter  (center,  right).  
  
A  second  independent  verification  of  dose  was  made  with  Gafchromic  EBT2  
radiochromic  film  (Ashland,  Covington,  KY).    The  radiochromic  film  was  calibrated  
(units  of  intensity  loss/Gy)  by  irradiating  several  small  pieces  of  film  from  the  same  
batch  to  known  doses  with  a  6MV  treatment  beam  (energy  dependence  assumed  
negligible),  and  comparing  counts  both  pre-­‐‑  and  post-­‐‑  irradiation  through  an  Expression  
10000  XL  film  scanner  (Epson,  Nagano,  Japan).    Square  ROIs  were  drawn  on  each  film  
slice,  and  average  intensity  loss  was  plotted  vs.  dose,  and  fitted  with  a  high-­‐‑dose  and  
low-­‐‑dose  quadratic  fit  [Figure  9].      
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Figure  9  -­‐‑  Bi-­‐‑quadratic  fit  of  radiochromic  film  used  for  absolute  dose  verification.  
  
In  order  to  verify  dose  distributions  in  two  orthogonal  planes,  the  imaging  and  
dosimetric  phantoms  were  both  machined  in  half  at  isocenter  in  the  coronal  and  axial  
dimensions  (1  each).    Film  was  placed  between  the  two  halves  and  the  180-­‐‑degree  arc  
treatment  was  repeated  for  each  dosimeter  [Figure  10].    To  measure  absolute  dose  
distributions  in  the  axial  and  coronal  film  slices  inserted  into  PRESAGE,  intensity  loss  
between  pre-­‐‑  and  post-­‐‑irradiation  scans  of  the  film  was  converted  to  dose  through  the  
calibration  fit  equation.    Figures  11  and  12  show  line  profiles  through  the  axial  and  
coronal  slices,  respectively.    Maximum  error  calculated  was  ~3%  between  film  and  
PRESAGE  dose  measurement  –  except  for  slight  optical-­‐‑CT  dose  under-­‐‑estimation  along  
the  3mm-­‐‑narrow  field.    Further  investigation  is  required  to  reconcile  this  dose  
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difference,  which  may  be  caused  due  to  a  stray  light  artifact  that  has  been  shown  in  
previous  work  to  effect  regions  of  steep  dose  gradients  with  small  fields33.  
  
  
Figure  10  -­‐‑  Schematic  showing  placement  of  radiochromic  film  for  independent  
measurement  of  dose  distributions.  
Coronal Axial 
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Figure  11  -­‐‑  Axial  dose  distributions  measured  with  optical-­‐‑CT  (top  row)  and  EBT2  
film  (middle  row),  with  comparative  line  profiles  (bottom  row).  
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Figure  12  -­‐‑  Coronal  dose  distributions  measured  with  optical-­‐‑CT  (top  row)  and  EBT2  
film  (middle  row),  with  comparative  line  profiles  (bottom  row).    Profile  4  shows  a  
dose  underestimate  with  optical-­‐‑CT.    This  may  be  due  to  partial  volume  effects  in  
reproducing  dose  in  the  3mm-­‐‑wide  field  with  0.5mm  voxels.  
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One  benefit  of  rodent-­‐‑morphic  dosimeters  is  the  ability  to  overlay  dose  
distributions  directly  onto  original  rodent  CT  data.    Figure  13  shows  micro-­‐‑SBRT  dose  
distributions  in  transverse  and  coronal  planes.    Distributions  as  presented  are  assumed  
in  homogeneous  tissue.    Future  work  is  required  for  modification  of  dose  from  
homogenous  to  heterogeneous  rodent  composition,  including  an  investigation  of  
optical-­‐‑CT  readout  in  PRESAGE  dosimeters  with  heterogeneous  inserts  (such  as  spinal  
imaging  insert  presented  here).          
  
  
Figure  13  -­‐‑  PRESAGE  dose  distributions  overlaid  on  original  rat  CT  from  which  the  
3D  printing  was  made,  in  axial  (left)  and  coronal  (right)  planes.  
  
  
3.3.3 Mouse partial tumor irradiation pilot study 
Recent  research  in  tumor  radiobiology  has  uncovered  some  progressive  theories  
regarding  the  formation  of  metastatic  cancers  post-­‐‑irradiation.    Theoretically,  the  highly  
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use  of  conformal  radiation  beams  pre-­‐‑planned  on  high  resolution  patient  CT  data  
should  minimize  the  risk  of  “missing”  cancerous  cells  within  the  targeted  region.    The  
failure  to  irradiate  a  tumor  volume  in  its  entirety,  known  as  a  “marginal-­‐‑miss”,  may  
have  consequences  other  than  just  the  survival  of  some  cancer  cells34,  35.      
The  pre-­‐‑clinical  small  animal  setting  is  ideal  for  testing  new  ideas  in  tumor  
biology.    Bold  claims  in  the  efficacy  or  consequences  resulting  from  unique  radiation  
treatments  in  small  animals  necessitate  high  resolution  and  accurate  confirmation  of  
dose  distributions  given  by  the  small-­‐‑animal  irradiator.    
In  collaboration  with  a  radiation  biology  group  at  Duke  University,  a  
homogenous  rodent-­‐‑morphic  mouse  dosimeter  was  produced  directly  from  mouse  CT  
data  in  the  same  fashion  as  described  in  Section  3.2.    As  of  the  time  of  this  writing,  
several  pilot  studies  have  been  performed  to  evaluate  the  feasibility  of  imaging  optical-­‐‑
CT  readouts  and  dose  distributions  in  high-­‐‑resolution  (0.3mm  isotropic)  with  a  further  
scaled  down  analogue  of  the  DLOS  system,  the  DmicrOS.    
  
3.3.3.1  Rodent-­‐‑morphic  mouse  dosimeter  
   Figure  14  shows  the  3D  mesh  file  used  for  creation  of  the  PRESAGE  rodent-­‐‑
morphic  dosimeter,  as  well  as  an  optical-­‐‑CT  projection  image  of  the  resulting  dosimeter.    
For  this  pilot  study,  a  tumor  volume  was  segmented  to  enable  isocentric  placement  at  
one  side  of  the  tumor.    The  mouse  phantom  was  placed  in  the  prone  position  on  the  
     29  
carbon-­‐‑fiber  treatment  stage  of  the  X-­‐‑Rad225Cx,  with  a  lead  block  placed  in  the  field  to  
shield  approximately  half  of  the  tumor  volume.    The  mouse  was  then  treated  with  
simple  anterior-­‐‑posterior  field.    Currently  being  investigated  is  the  dose  drop-­‐‑off  at  the  
interface  between  the  irradiated  and  blocked  tumor  volume  [Figure  15].    Future  work  
will  involve  an  investigation  of  a  partial  tumor  arc  treatment,  as  well  as  feasibility  of  
accurate  dose  volume  histogram  (DVH)  calculations  from  overlaying  3D  dose  
distributions  onto  original  mouse  CT  data.  
  
  
Figure  14  -­‐‑  3D  mesh  file  (top  left)  created  from  mouse  CT  data  and  used  for  PRESAGE  
mouse  dosimeters  (top  right,  American  penny  for  scale).    The  bottom  image  shows  an  
optical-­‐‑CT  projection  taken  with  the  DmicrOS  system.  




Figure  15  -­‐‑  Preliminary  partial  tumor-­‐‑irradiation  data  showing  sharp  dose  drop-­‐‑off  at  
full  field/  blocked  field  interface.  
  
3.4 Rodent-morphic dosimetry discussion 
For  the  first  time,  accurate  dose-­‐‑distribution  readout  is  available  in  high-­‐‑
resolution  rodent-­‐‑morphic  phantoms  for  small  animal  micro-­‐‑irradiators.    Variable  
density  PRESAGE  provided  adequate  contrast  to  be  a  viable  method  of  CBCT  targeting  
and  isocenter  placement  on  the  X-­‐‑Rad225Cx  irradiator,  while  optical-­‐‑CT  readout  
provides  an  accurate  dose  measurement  when  compared  to  direct  exposure  
measurement.    While  this  study  focused  on  rat  spine/outer  body  and  mouse  body  
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contours,  any  volume  of  interest  may  be  segmented,  converted  to  3D-­‐‑printible  file,  and  
made  into  a  mold  for  PRESAGE  anatomically  accurate  phantoms.    This  method  of  dose  
measurement  allows  for  high-­‐‑resolution  of  complex  treatment  paradigms  being  used  in  
the  pre-­‐‑clinical  setting,  and  enhances  the  robustness  of  tumor  biology  and  radio-­‐‑
response  studies  in  the  small  animal  regime.      
For  future  work,  heterogeneous  rodent-­‐‑morphic  dosimeters  with  one  or  more  
anatomical  inserts  will  be  investigated.    Dose  calculations  with  beams  in  the  kV  range  
are  more  sensitive  to  heterogeneous  tissues,  so  an  anatomically  correct  rodent-­‐‑morphic  
dosimeter  consisting  of  PRESAGE  inserts  of  varying  effective-­‐‑Z  would  be  more  ideal  for  
high-­‐‑resolution  dose  readout  given  by  small  animal  irradiators.    PRESAGE-­‐‑def  is  a  
dosimeter  formulation  able  to  be  deformed  with  3  degrees  of  freedom  and  relaxed  back  
into  the  initial  size  and  shape.    Complex  deformation  of  human  organs  (i.e.  liver,  lungs)  
may  also  be  simulated  through  3D  printing  of  human  anatomy  and  production  of  
anatomically  accurate  anthropomorphic  dosimeters.    This  may  be  accomplished  using  
the  same  series  of  production  steps  presented  here.  
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4. Feasibility of ‘Dry’ Scanning 
One  of  the  distinct  challenges  in  optical-­‐‑CT  is  the  method  for  directing  incident  light  
through  a  sample  and  into  a  detector  or  CCD  array  in  a  straight  path  with  minimal  
deviation  due  to  refraction  at  the  air/dosimeter  interfaces.    Telecentric  lenses  may  be  
used  to  achieve  parallel-­‐‑beam  geometry  for  the  incident  light,  while  immersing  the  
dosimeter  in  a  fluid  of  similar  refractive  index  minimizes  refraction.      
For  this  work,  two  questions  were  addressed:    (1)  Can  the  bulky,  expensive,  
telecentric  lenses  be  replaced  by  a  more  manageable  Fresnel  lens  system?  And  (2)  can  
the  cumbersome  refractive  index-­‐‑matching  fluid  be  minimized36,  37?    This  work  
introduces  the  Duke  Fresnel  dry  Optical-­‐‑CT  System  (DFOS),  an  analogue  to  the  Duke  




The  DFOS  system  replaces  the  convex  telecentric  lenses  used  in  the  DLOS  system  
with  a  Fresnel  lens  system  (Light  Works,  Toledo,  OH),  resulting  in  cost  savings  of  
around  99%  (~$4000  to  ~$40),  and  a  lens  weight  reduction  from  ~7kg  to  500g  [Figure  16].    
Fresnel  lenses  have  inherent  non-­‐‑uniformity  due  to  the  Fresnel  grooves,  and  a  Moiré  
effect  is  noticeable  when  imaging  with  a  pair  of  lenses  in  a  telecentric  setup.      
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Figure  16  -­‐‑  Comparison  of  parallel-­‐‑beam  collimation  from  Fresnel  and  Convex  lenses.    
Equivalent  power  Fresnel  lenses  may  be  100X  less  expensive  and  close  to  15X  lighter  
than  convex  collimating  lenses.  
  
Non-­‐‑uniformities  from  the  Fresnel  lenses  can  be  reduced  by:  (1)  ensuring  proper  focus  
of  the  system  directly  between  the  pair  of  lenses,  and  (2)  decreasing  the  aperture  (focal  
ratio)  of  the  lens  at  the  camera  side  (increasing  the  f-­‐‑number,  illustrated  in  Figure  17),  
while  increasing  the  LED  output  aperture.    The  decreased  aperture  at  the  camera  side  
allows  for  a  larger  field-­‐‑of  view,  and  reduces  the  sensitivity  to  slight-­‐‑refractive  
variations  form  the  Fresnel  lens.    Any  remaining  imperfections  or  non-­‐‑uniformities  
should  be  theoretically  corrected  for  by  taking  projection  images  both  before  and  after  
dosimeter  irradiation.    
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Figure  17  -­‐‑  Non-­‐‑uniformities  caused  by  Fresnel  grooves  (left)  may  be  reduced  by  
increasing  the  f-­‐‑stop  (right)  at  the  imaging  lens.    Remaining  non-­‐‑uniformities  are  
corrected  by  acquiring  pre-­‐‑  and  post-­‐‑irradiation  images.      
  
Another  modification  to  the  DLOS  system  present  in  the  DFOS  is  the  minimal  fluid  
bath.    Refractive  index  matching  fluid  is  used  in  optical-­‐‑CT  to  allow  incident  light  to  
pass  through  the  dosimeter  in  a  parallel  path  without  refraction  at  the  interface  between  
two  media.    For  the  DFOS  system,  the  glass  aquarium  was  replaced  with  a  17x17x17  cm3  
polyurethane  cube  with  a  cylindrical  bore  of  diameter  11.5cm  and  height  10cm,  allowing  
for  placement  of  an  11cm  diameter  x  10cm  dosimeter.    The  2.5mm  air  gap  surrounding  
the  dosimeter  requires  ~90  cm3  of  fluid  of  match  the  refractive  index  between  the  
polyurethane  tank  (RI  =  1.5)  to  PRESAGE  dosimeters  (RI  =  1.47-­‐‑1.51),  compared  to  
~13500  cm3  of  fluid  for  the  DLOS  system.      
In  the  absence  of  a  dosimeter,  the  “dry”  polyurethane  tank  essentially  becomes  an  
air-­‐‑gap,  refracting  all  incident  light  out  of  the  CCD  field-­‐‑of-­‐‑view.    Theoretically,  an  
incident  light  image  or  “flood”  field  may  be  acquired  by  filling  the  tank  with  fluid  
matched  to  the  polyurethane  tank.    This  would  not  only  require  more  fluid  handling,  but  
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an  RI  mismatch  between  the  tank  (and  fluid  used  for  flood)  and  dosimeter  would  cause  
a  loss  of  signal  at  the  dosimeter  edges,  manifesting  as  dark  bands  [Figure  18].      For  all  
DFOS  image  acquisitions,  the  flood  field  image  was  purposefully  omitted.    This  assumes  
that  the  LED  output,  and  therefore  incident  light,  remains  constant  between  pre-­‐‑  and  
post-­‐‑irradiation  scans.      
  
  
Figure  18  -­‐‑  Flood  field  acquired  by  filling  the  DFOS  polyurethane  tank  with  RI-­‐‑
matching  fluid  (left).    Matching  the  fluid  to  the  tank  achieves  good  uniformity  all  the  
way  to  the  edges,  but  immersing  a  dosimeter  of  different  refractive  index  into  the  
fluid  causes  mismatching  artifacts  at  the  edge  (right).    This  phenomena,  combined  
with  the  desire  to  minimize  fluid  handling,  drove  the  decision  to  omit  the  flood  field  
altogether.        
  
To  investigate  the  consequence  of  omitting  the  flood  field,  high  dynamic  range  
DLOS  data  was  reconstructed  both  with  and  without  flood  fields  and  compared.    Figure  
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19  shows  dose  line  profiles  through  3  Gy,  6  Gy,  and  9.5  Gy  dose  regions  both  with  and  
without  flood  fields,  and  corresponding  dose  error  assuming  PRESAGE  dosimeter  with  
sensitivity  0.05  OD  change/cm-­‐‑Gy  (a  typical  value  seen  in  PRESAGE  formulations).    
Maximum  dose  error  for  this  representative  case  was  4.6  cGy,  occurring  in  the  6  Gy  dose  
region.    This  corresponds  to  a  0.77%  absolute  dose  difference.    Further  investigation  into  
the  LED  consistency  and  the  validity  of  flood  field  omission  is  required.    
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Figure  19  -­‐‑  Comparison  of  line  profile  through  a  slice  reconstructed  with  and  without  
a  flood  field  projection.    Maximum  computed  dose  error  in  this  case  is  only  4.2  cGy.  
  
4.2 Treatment plans 
To  evaluate  the  DFOS  system,  3  treatments  were  given  to  PRESAGE  
radiochromic  dosimeters.    For  all  treatments,  CT  scans  were  taken  of  the  dosimeter  and  
imported  to  the  Eclipse  (Varian  Medical  Systems,  Palo  Alto,  CA)  treatment  planning  
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software  (TPS)  for  dose  prediction  for  each  treatment.  Dose  was  delivered  by  6MV  
beams  at  a  dose  rate  of  600  MU/min  for  all  irradiations.    Comparisons  were  made  
varying  dosimeter  formulations,  treatment  plans,  and  optical-­‐‑CT  systems,  by  computing  
the  gamma  passing  rate  at  a  threshold  of  3%/3mm  with  respect  to  TPS  prediction  for  all  
optical-­‐‑CT  reconstructions.    Table  2  below  shows  a  summary  of  all  irradiation  plans,  
scanner  comparisons,  and  dosimeter  formulations.    For  this  preliminary  study,  relative  
dose  was  converted  to  absolute  dose  by  making  a  point  measurement  in  the  Eclipse  
predicted  dose  distribution  and  scaling  the  optical-­‐‑CT  reconstructed  OD-­‐‑change  
accordingly.    This  step  was  justified  as  PRESAGE  has  been  shown  to  exhibit  a  strong  
linear  optical  density  change  with  absorbed  dose.  
  
Table  2  –  Summary  of  all  scanner  comparison  parameters,  including:  treatment  
description,  dosimeter  formulation  description,  systems  being  compared,  and  delay  
between  treatment  and  post-­‐‑irradiation  scan.  
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4.2.1 Rectangular orthogonal parallel-opposed treatment I 
The  first  treatment  consisted  of  two  orthogonal  sets  of  parallel-­‐‑opposed  4cm  x  
10cm  beams,  delivered  to  a  cylindrical  11cm  diameter  x  10cm  PRESAGE  dosimeter.    
Dose  was  configured  in  order  to  have  3  distinct  dose  regions  by  delivering  200  monitor  
units  each  for  the  right/left  lateral  and  left/right  lateral  beams  (low  dose)  and  300  
monitor  units  each  for  the  anterior/posterior  and  posterior/anterior  beams  (medium  
dose),  leaving  a  high  dose  cube  in  the  center  of  the  distribution  [Figure  20].    Projection  
images  were  taken  over  360-­‐‑degrees  at  1-­‐‑degree  increments  with  the  DFOS  scanner  both  
before  and  after  irradiation  and  reconstructed  at  2mm  resolution  with  a  custom  
MATLAB  GUI.      
  
4.2.2 Rectangular orthogonal parallel-opposed treatment II 
The  second  irradiation  was  similar  to  irradiation  1,  with  the  key  difference  being  
a  comparison  between  3  available  scanners  –  the  DMOS,  DLOS,  and  DFOS  –  relative  to  
Eclipse  TPS.    An  11cm  diameter  x  10cm  dosimeter  was  irradiated  with  two  sets  of  
parallel  opposed  beams,  with  dose  again  being  separated  into  three  distinct  regions  
[Figure  20].    For  all  3  optical-­‐‑CT  systems,  360  projections  were  acquired  at  1-­‐‑degree  
increments  and  reconstructed  with  2mm  isotropic  voxels.    
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4.2.3 Brain IMRT treatment 
The  final  irradiation  was  performed  on  a  third  cylindrical  11cm  diameter  x  10cm  
PRESAGE  dosimeter.    Treatment  consisted  of  a  5-­‐‑field  brain  IMRT  plan  to  be  delivered  
to  the  cylindrical  dosimeter  through  a  plastic  tissue-­‐‑equivalent  head  phantom  [Figure  
20].    Projection  images  were  taken  again  at  360  1-­‐‑degree  increments  and  reconstructed  at  
2mm  resolution  with  both  the  DLOS  and  DFOS  systems,  to  enable  comparison  of  DFOS  
performance  with  both  Eclipse  prediction  and  the  gold-­‐‑standard  DLOS  system.    
Comparison  of  both  reconstructions  with  Eclipse  prediction  were  again  preformed  by  
computing  the  3%/3mm  gamma  index.  
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Figure  20  -­‐‑  Rectangular  parallel-­‐‑opposed  I  (left),  II  (center)  and  five-­‐‑field  brain  IMRT  
(right)  treatment  plans  from  Eclipse  TPS.  
  
  
4.3 Results of ‘Dry’ Scan Comparison 
   Initial  comparison  of  DFOS  dose  distributions  showed  promising  results.    DFOS  
reconstruction  for  parallel-­‐‑opposed  treatment  plan  I  had  a  gamma  index  pass  rates  of  
89.3%  with  a  3%/3mm  criteria  compared  to  Eclipse  TPS  prediction,  showing  promise  but  
substantially  less  accurate  than  desired.    For  the  brain  IMRT  plan,  the  DFOS  dose  had  a  
gamma  pass  rate  of  87.5%  -­‐‑  again  promising  but  not  optimal  when  compared  to  the  
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DLOS  gamma  pass  rate  of  99.0%  for  the  same  treatment.    For  the  parallel-­‐‑opposed  
treatment  II,  the  DFOS,  DLOS,  and  DMOS  were  all  compared  with  Eclipse  prediction.    A  
slight  rounding  of  all  steep  dose  gradients  was  observed  with  all  three  systems  –  which  
may  be  due  to  dosimeter  formulation  changes  or  diffusion  of  signal  between  irradiation  
and  post-­‐‑iradiation  scanning,  which  was  performed  20  hours  later.    However,  the  
gamma  pass  rates  for  the  DFOS,  DLOS,  and  DMOS  were  92.2%,  95.6%,  and  96.8%,  
respectively,  compared  to  Eclipse  prediction.    It  should  be  noted  that  DLOS  and  DMOS  
distribution  matched  almost  perfectly  (99.0%  when  compared  to  each  other),  showing  
both  systems  to  be  performing  optimally  at  this  time.    Table  3  below  summarizes  all  
gamma  pass  rates  for  all  treatments  compared  to  Eclipse  TPS  prediction.  
      
Table  3  –  Summary  of  gamma  3%/3mm  pass  rates  for  all  irradiations    
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Figure  21  shows  orthogonal  slices  of  predicted  and  measured  dose  for  the  parallel-­‐‑
opposed  plan  I,  along  with  gamma  views.      Figures  22-­‐‑25  show  orthogonal  views  for  the  
parallel-­‐‑opposed  II  [Figure  22]  and  brain  IMRT  [Figure  24]  plans  for  predicted  and  
optical-­‐‑CT  measured  dose  show  orthogonal  views  of  predicted  and  measured  dose,  
while  Figures  23  and  25  show  gamma  map  slices  for  the  parallel-­‐‑opposed  II  treatment  
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Figure  21  -­‐‑  Eclipse  predicted  dose  (left),  DFOS  reconstructed  dose  (middle)  and  
3%/3mm  gamma  maps  (right)  for  three  orthogonal  planes  in  parallel-­‐‑opposed  
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Figure  22  -­‐‑  Eclipse  predicted  dose  (left),  DFOS  reconstructed  dose  (second  column),  
DMOS  reconstructed  dose  (third  column)  and  DLOS  reconstructed  dose  (right)  for  









     46  
  
Figure  23  -­‐‑  Three  orthogonal  views  of  3%/3mm  gamma  maps  for  DFOS  (column  2),  
DMOS  (column  3),  and  DLOS  (right)  systems,  with  passing  rates.    Eclipse  dose  views  
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Figure  24  -­‐‑  Eclipse  predicted  dose  (left),  DFOS  reconstructed  dose  (middle)  and  DLOS  
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Figure  25  -­‐‑  Three  orthogonal  views  of  3%/3mm  gamma  maps  for  DFOS  (column  2)  
and  DLOS  (right)  systems,  with  passing  rates.    Eclipse  dose  views  (left)  for  reference.  
  
  
The  following  figures    [Figures  26-­‐‑34]  show  line  profiles  through  various  
orthogonal  planes  for  each  of  the  3  treatment  plans.    Some  notable  takeaways  –  the  
DLOS  system  performed  optimally  for  reproducing  brain  IMRT  dose  distributions,  
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while  the  DMOS  matched  the  DLOS  in  the  second  parallel-­‐‑opposed  treatment.    DFOS  
line  profiles  show  a  substantial  increase  in  noise  when  compared  to  DLOS  and  DMOS  
reconstructions.    Although  concurrent  work  showed  the  optimal  dose-­‐‑readout  time  for  
the  DEA  PRESAGE  formulation  to  be  3-­‐‑24  hours  post-­‐‑irradiation,  there  is  a  significant  
rounding  of  sharp  dose  gradients  shown  with  the  all  three  systems  in  the  second  
parallel-­‐‑opposed  treatment,  which  was  readout  ~20  hours  post-­‐‑irradiation.    This  is  in  
comparison  to  a  near  perfect  representation  with  the  DLOS  IMRT  reconstruction,  which  
features  sharp  dose  gradients  as  well,  but  with  readout  performed  3  hours  post-­‐‑
irradiation.    Further  investigation  is  needed  to  determine  the  reason  for  these  
inconsistencies.  
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4.3.1 Line Profiles – Parallel-opposed treatment I 
  
Figure  26  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  I  comparing  Eclipse  
prediction  (black),  and  DFOS  dose  (blue).  
  
  
Figure  27  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  I  comparing  Eclipse  
prediction  (black),  and  DFOS  dose  (blue).  
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Figure  28  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  I  comparing  Eclipse  
prediction  (black),  and  DFOS  dose  (blue).  
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4.3.2 Line Profiles – Parallel-opposed treatment II 
  
Figure  29  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  II  comparing  Eclipse  
prediction  (black),  DFOS  (blue),  DMOS  (green),  and  DLOS  (red)  dose.  
  
  
Figure  30  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  II  comparing  Eclipse  
prediction  (black),  DFOS  (blue),  DMOS  (green),  and  DLOS  (red)  dose.  
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Figure  31  -­‐‑  Line  profiles  for  parallel-­‐‑opposed  treatment  II  comparing  Eclipse  
prediction  (black),  DFOS  (blue),  DMOS  (green),  and  DLOS  (red)  dose.  
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4.3.3 Line Profiles – Brain IMRT treatment 
  
Figure  32  -­‐‑  Line  profiles  for  brain  IMRT  treatment  comparing  Eclipse  prediction  
(black),  DFOS  (blue),  and  DLOS  (red)  dose.  
  
Figure  33  -­‐‑  Line  profiles  for  brain  IMRT  treatment  comparing  Eclipse  prediction  
(black),  DFOS  (blue),  and  DLOS  (red)  dose.  
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Figure  34  -­‐‑  Line  profiles  for  brain  IMRT  treatment  comparing  Eclipse  prediction  
(black),  DFOS  (blue),  and  DLOS  (red)  dose.  
  
4.4 ‘Dry’ Scan Discussion  
   Because  of  the  two  drastic  changes  incorporated  into  the  DFOS  system,  several  
considerations  must  be  made  when  comparing  with  the  current  gold  standard  DLOS  
system.    The  Fresnel  lenses  produce  obvious  non-­‐‑uniformities  in  the  incident  light  field,  
which  can  only  be  corrected  for  when  alignment  is  reproduced  exactly  between  the  pre-­‐‑  
and  post-­‐‑irradiation  scans.    Therefore,  special  attention  needs  to  be  paid  to  avoiding  any  
changes  in  setup  geometry.    Minimizing  the  fluid  necessary  for  “dry”  scanning  has  
obvious  implications  for  the  practicality  of  optical-­‐‑CT,  as  well  as  decreasing  the  
likelihood  of  imperfections  in  the  fluid  bath  causing  ring  artifacts  in  the  reconstructed  
image.  
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   Overall,  first  attempts  for  imaging  3D  dose  distribution  with  an  optical-­‐‑CT  
system  with  minimal  fluid  and  Fresnel  lenses  is  promising.    The  largest  source  of  error  
seems  to  be  regions  of  high  optical  attenuation.    Further  investigation  is  required  to  
improve  3%/3mm  gamma  pass  rates  from  the  85-­‐‑90%  range.    With  a  gamma  pass  rate  of  
99%,  the  DLOS  gold  standard  system  is  performing  optimally,  with  the  DMOS  system  
seeming  to  match  DLOS  performance.              
  
    
     57  
5. Conclusion 
As  we  learn  more  about  the  biological  mechanisms  behind  both  the  spread  of  
cancer  and  the  tumor  response  to  radiation  therapy,  the  small  animal  pre-­‐‑clinical  setting  
will  become  an  increasingly  significant  scientific  realm.    Small  animal  radio-­‐‑response  
research  gives  new  theoretical  insights  into  radiation  therapy.    These  small  animal  
platforms  give  an  opportunity  to  make  the  translation  from  small  cell-­‐‑line  studies  and  
simulations  to  human  care  in  much  the  same  way  that  clinical  trials  for  drugs  are  carried  
out  presently.    As  our  understanding  of  tumor  radio-­‐‑response  becomes  more  “high-­‐‑
resolution”,  a  similarly  high-­‐‑resolution  verification  of  doses  given  in  the  pre-­‐‑clinical  
setting  is  essential.  
In  this  work  a  powerful  new  pre-­‐‑clinical  tool  for  high-­‐‑resolution  3D  dosimetry  in  
anatomically  accurate  rodent  phantoms  was  presented  and  verified.    Although  only  a  
mouse  and  rat  were  studied,  this  workflow  allows  any  anatomy  of  interest  to  be  scanned  
and  printed  into  a  3D  dosimetric  phantom,  with  varying  densities  and  compositions.    
Optical-­‐‑CT  with  PRESAGE  rodent-­‐‑morphic  dosimeters  was  shown  to  be  accurate.    
Challenges  related  to  cost  and  convenience  involved  in  the  acquiring  of  optical-­‐‑CT  
images  were  also  addressed,  with  the  Duke  Fresnel-­‐‑based  Optical-­‐‑CT  System  (DFOS)  
showing  much  promise  as  a  practical  and  viable  system,  although  currently  well  behind  
the  capability  of  the  telecentric  lens  based  DMOS  and  DLOS  system.  
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